Oral peanut immunotherapy in children with peanut anaphylaxis

Long-term OIT appears to be safe and of some benefit in many patients with peanut allergy. With an increase in threshold levels and a reduction of peanut-specific TH2 cytokine production, the induction of tolerance may be feasible in some patients.